Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents
Letters in Applied Microbiology · 16.02.2023 · 76 (2)
DOI: 10.1093/lambio/ovac026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, online erschienen am 14.12.2022. Verfasst von Yedukondalu Nalli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products and Green Chemistry Division, CSIR-Central Salt and Marine Chemicals Research Institute (CSIR-CSMCRI), Council of Scientific and Ind…. Hauptthemen laut MEDLINE: Siderophores, Mycobacterium tuberculosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Council of Scientific and Industrial Research.
Abstract (Originalsprache)
The bacterial endophytes isolated from the halophyte Salicornia brachiata were explored for the antimicrobial potential to discover novel microbial inhibitors that combat multidrug resistance. Upon investigation, ethyl acetate extract of the endophyte Bacillus subtilis NPROOT3 displayed significant potency against Mycobacterium smegmatis MTCC6 as well as Mycobacterium tuberculosis H37Rv strain. Further investigation of ethyl acetate crude extract by repeated chromatographic separations followed by characterization using UV, HR-ESI-MS, MALDI-MS, MALDI-MS/MS, CD, and NMR spectroscopy yielded a series of five known siderophores, namely, SVK21 (1), bacillibactin C (2), bacillibactin B (3), tribenglthin A (4), and bacillibactin (5). A total of two out of five compounds, 4 (MIC 38.66 μM) and 5 (MIC 22.15 μM) exhibited significant inhibition against the strain M. smegmatis MTCC6 comparable with positive control rifampicin (MIC 12.15 μM). None of these five bacillibactin molecules are previously reported to exhibit bioactivity against Mycobacterium sp. Herein for the first time, all the compounds were screened for their antibacterial activities against a panel of bacterial pathogens of humans. Furthermore, the probable mechanism of action of bacillibactin compounds for their antimycobacterial activity is also discussed. The findings of this study open up a new chemotype for inhibition of the Mycobacterium sp. and other multidrug-resistant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural Products and Green Chemistry Division, CSIR-Central Salt and Marine Chemicals Research Institute (CSIR-CSMCRI), Council of Scientific and Industrial Research (CSIR), Bhavnagar 364002, Gujarat, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Department of Bacteriology, National Institute for Research in Tuberculosis, ICMR, Sathyamoorty Road, Chetpet, Chennai 31, Tamil Nadu, India.
Förderung
- Science and Engineering Research Board
- Department of Science and Technology
- Council of Scientific and Industrial Research
Zitieren
APA
Nalli, Y., Singh, S., Gajjar, A., Mahizhaveni, B., Dusthackeer, V. N. A., & Shinde, P. B. (2023). Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents. Letters in Applied Microbiology, 76(2). https://doi.org/10.1093/lambio/ovac026
Vancouver
Nalli Y, Singh S, Gajjar A, Mahizhaveni B, Dusthackeer VNA, Shinde PB. Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents. Letters in Applied Microbiology. 2023;76(2). doi:10.1093/lambio/ovac026
BibTeX
@article{Nalli2023,
author = {Nalli, Yedukondalu and Singh, Sanju and Gajjar, Apexa and Mahizhaveni, Balasubramanian and Dusthackeer, Vijayan Nynar Azger and Shinde, Pramod B},
title = {Bacillibactin class siderophores produced by the endophyte Bacillus subtilis NPROOT3 as antimycobacterial agents},
journal = {Letters in Applied Microbiology},
year = {2023},
volume = {76},
number = {2},
doi = {10.1093/lambio/ovac026}
}
EUVIMED